Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer

[MEDPAGE TODAY]( Oncology Update Friday, July 19, 2024 [Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer]( [EHR 'Nudge' Cut Low-Value Surgery Rates in Older Breast Cancer Patients]( [Risk of Ovarian Cancer Higher in Women With Endometriosis]( [Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A]( ['Realistic Chance for Pregnancy' After Stem Cell Transplant, German Study Suggests]( ADVERTISEMENT Exclusives & Features [These 'Zebra' Cases Were Cracked by People Other Than Doctors]( [How Unionization Changed Surgery Residency Programs]( [Women with endometriosis face fourfold higher risk of ovarian cancer, study suggests | CNN]( The risk of developing ovarian cancer appears to jump about fourfold among women with endometriosis, compared with women who haven’t been diagnosed with the condition, a new study finds. [READ MORE]( [Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access]( It's much less likely that cancer patients who are racial minorities find the perfect match for a bone marrow transplant. A new study finds that maybe imperfect donor matches will still work well. [READ MORE]( [Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.]( Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or... [READ MORE]( [Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.]( PURPOSE: Access to allogeneic hematopoietic cell transplantation (HCT) remains limited among persons of non-European ancestry if human leukocyte antigen (HLA) matching is required. We evaluated... [READ MORE]( [Targeting AKR1B10 by drug repurposing with epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids.]( PURPOSE: Systemic treatments given to non-small cell lung cancer (NSCLC) patients are often ineffective due to drug resistance. In the present study, we investigated patient-derived tumor organoids... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-07-19&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011